Report: BI sued on asthma inhaler

A Florida man has sued Ridgefield-based Boehringer Ingelheim Pharmaceuticals in Connecticut federal court, claiming the company has failed to provide a promised number of doses in its Combivent Respimat inhalers that treat asthma by relaxing the lung’s muscles. Plaintiff Carl Ignacuinos is seeking class-action status for his complaint in which he alleges that Boehringer Ingelheim marketed the inhalers as having 120 doses, but that the devices in some cases had half that many.